The structural basis for recognition of Human Leukocyte Antigen Class I molecules by the pan-HLA antibody W6/32

Journal article


Pymm, Phillip, Saunders, Philippa M., Anand, Sushma, MacLachlan, Bruce J., Faoro, Camilla, Hitchen, Corinne, Rossjohn, Jamie, Brooks, Andrew G. and Vivian, Julian P.. (2024). The structural basis for recognition of Human Leukocyte Antigen Class I molecules by the pan-HLA antibody W6/32. Journal of Immunology. 213(6), pp. 876-885. https://doi.org/10.4049/jimmunol.2400328
AuthorsPymm, Phillip, Saunders, Philippa M., Anand, Sushma, MacLachlan, Bruce J., Faoro, Camilla, Hitchen, Corinne, Rossjohn, Jamie, Brooks, Andrew G. and Vivian, Julian P.
Abstract

The central immunological role of HLA class I (HLA-I) in presenting peptide Ags to cellular components of the immune system has been the focus of intense study for >60 y. A confounding factor in the study of HLA-I has been the extreme polymorphism of these molecules. The mAb W6/32 has been a fundamental reagent bypassing the issue of polymorphism by recognizing an epitope that is conserved across diverse HLA-I allotypes. However, despite the widespread use of W6/32, the epitope of this Ab has not been definitively mapped. In this study, we present the crystal structure of the Fab fragment of W6/32 in complex with peptide–HLA-B*27:05. W6/32 bound to HLA-B*27:05 beneath the Ag-binding groove, recognizing a discontinuous epitope comprised of the α1, α2, and α3 domains of HLA-I and β2-microglobulin. The epitope comprises a region of low polymorphism reflecting the pan–HLA-I nature of the binding. Notably, the W6/32 epitope neither overlaps the HLA-I binding sites of either T cell Ag receptors or killer cell Ig-like receptors. However, it does coincide with the binding sites for leukocyte Ig-like receptors and CD8 coreceptors. Consistent with this, the use of W6/32 to block the interaction of NK cells with HLA-I only weakly impaired inhibition mediated by KIR3DL1, but impacted HLA-LILR recognition.

Year2024
JournalJournal of Immunology
Journal citation213 (6), pp. 876-885
PublisherOxford University Press
ISSN0022-1767
Digital Object Identifier (DOI)https://doi.org/10.4049/jimmunol.2400328
PubMed ID39093013
Scopus EID2-s2.0-85203126462
Page range876-885
FunderAustralian Research Council (ARC)
National Health and Medical Research Council (NHMRC)
Victorian Cancer Agency
Publisher's version
License
All rights reserved
File Access Level
Controlled
Output statusPublished
Publication dates
Online02 Aug 2024
Publication process dates
Accepted09 Jul 2024
Deposited07 Apr 2025
ARC Funded ResearchThis output has been funded, wholly or partially, under the Australian Research Council Act 2001
Grant IDDP230103117
2008981
MCRF20043
Additional information

Copyright © 2024 by The American Association of Immunologists, Inc.

Permalink -

https://acuresearchbank.acu.edu.au/item/91978/the-structural-basis-for-recognition-of-human-leukocyte-antigen-class-i-molecules-by-the-pan-hla-antibody-w6-32

Restricted files

Publisher's version

  • 15
    total views
  • 0
    total downloads
  • 15
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

Structure of the murine CD94–NKG2A receptor in complex with Qa-1b presenting an MHC-I leader peptide
MacLachlan, Bruce J., Sullivan, Lucy C., Brooks, Andrew G., Rossjohn, Jamie and Vivian, Julian P.. (2024). Structure of the murine CD94–NKG2A receptor in complex with Qa-1b presenting an MHC-I leader peptide. The FEBS Journal. 291(7), pp. 1530-1544. https://doi.org/10.1111/febs.17050
An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania
Loh, Liyen, Saunders, Philippa M., Faoro, Camilla, Font-Porterias, Neus, Nemat-Gorgani, Neda, Harrison, Genelle F., Sadeeq, Suraju, Hensen, Luca, Wong, Shu Cheng, Widjaja, Jacqueline, Clemens, E. Bridie, Zhu, Shiying, Kichula, Katherine M., Tao, Sudan, Zhu, Faming, Montero-Martin, Gonzalo, Fernandez-Vina, Marcelo, Guethlein, Lisbeth A., Vivian, Julian P., ... Norman, Paul J.. (2024). An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania. Cell. 187(24), pp. 7008-7024. https://doi.org/10.1016/j.cell.2024.10.005
Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs
Cornforth, Terri V., Moyo, Nathifa, Cole, Suzanne, Lam, Emily P. S., Lobry, Tatiana, Wolchinsky, Ron, Lloyd, Angharad, Ward, Katarzyna, Denham, Eleanor M., Masi, Giulia, Qing Yun, Phyllis Tea, Moore, Colin, Dhaouadi, Selsabil, Besra, Gurdyal S., Veerapen, Natacha, Illing, Patricia T., Vivian, Julian P., Raynes, Jeremy M., Le Nours, Jérôme, ... Dukes, Joseph. (2024). Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs. Frontiers in Oncology. 14, p. Article 1419528. https://doi.org/10.3389/fonc.2024.1419528
Complimentary electrostatics dominate T-cell receptor binding to a psoriasis-associated peptide antigen presented by human leukocyte antigen C∗06:02
Anand, Sushma, Littler, Dene R., Mobbs, Jesse I., Braun, Asolina, Baker, Daniel G., Tennant, Luke, Purcell, Anthony W., Vivian, Julian P. and Rossjohn, Jamie. (2023). Complimentary electrostatics dominate T-cell receptor binding to a psoriasis-associated peptide antigen presented by human leukocyte antigen C∗06:02. Journal of Biological Chemistry. 299(7), p. Article 104930. https://doi.org/10.1016/j.jbc.2023.104930
Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation
Jin, Dongbin, Loh, Khai Lee, Shamekhi, Tima, Ting, Yi Tian, Lim Kam Sian, Terry C. C., Roest, James, Ooi, Joshua D., Vivian, Julian Philip and Faridi, Pouya. (2023). Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation. In In Jenkins, Brendan J. (Ed.). Inflammation and Cancer : Methods and Protocols pp. 351-369 Springer - Humana Press. https://doi.org/10.1007/978-1-0716-3331-1_25
Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection
Ullah, Tomalika R., Johansen, Matt D., Balka, Katherine R., Ambrose, Rebecca L., Gearing, Linden J., Roest, James, Vivian, Julian Philip, Sapkota, Sunil, Jayasekara, W. Samantha N., Wenholz, Daniel S., Aldilla, Vina R., Zeng, Jun, Miemczyk, Stefan, Nguyen, Duc H. and et. al.. (2023). Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection. Nature Communications. 14(1), pp. 1-13. https://doi.org/10.1038/s41467-023-41381-9
Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1
de Weerd, Nicole A., Ogungbola, Olamide, Liu, Xinyun, Matthews, Antony Y., Ismail, Amina, Vivian, Julian Philip, Lim, San S., Tyrrell, D. Lorne, Putcha, Niru, Skawinski, Mike, Dickensheets, Harold, Lavoie, Thomas B., Donnelly, Raymond P., Hertzog, Paul J. and Santer, Deanna M.. (2023). Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1. Journal of Interferon and Cytokine Research. 43(9), pp. 403-413. https://doi.org/10.1089/jir.2023.0040
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells
Palmer, William H., Leaton, Laura Ann, Codo, Ana Campos, Crute, Bergren, Roest, James, Zhu, Shiying, Petersen, Jan, Tobin, Richard P., Hume, Patrick S., Stone, Matthew, van Bokhoven, Adrie, Gerich, Mark E., McCarter, Martin D., Zhu, Yuwen, Janssen, William J., Vivian, Julian Philip, Trowsdale, John, Getahun, Andrew, Rossjohn, Jamie, ... Norman, Paul J.. (2023). Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science Immunology. 8(84), pp. 1-18. https://doi.org/10.1126/sciimmunol.ade5343
The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors
Mifsud, Nicole A., Illing, Patricia T., Ho, Rebecca, Tuomisto, Johanna E., Fettke, Heidi, Mullan, Kerry A., McCluskey, James, Rossjohn, Jamie, Vivian, Julian Philip, Reantragoon, Rangsima and Purcell, Anthony W.. (2023). The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors. Allergy. 78(11), pp. 2980-2993. https://doi.org/10.1111/all.15814
Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
Moradi, Shoeib, Stankovic, Sanda, O’Connor, Geraldine M., Pymm, Phillip, MacLachlan, Bruce J., Faoro, Camilla, Retière, Christelle, Sullivan, Lucy C., Saunders, Philippa M., Widjaja, Jacqueline, Cox-Livingstone, Shea, Rossjohn, Jamie, Brooks, Andrew G. and Vivian, Julian P.. (2021). Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C. Nature Communications. 12(1), p. Article 2173. https://doi.org/10.1038/s41467-021-22359-x
Growth hormone stops excessive inflammation after partial hepatectomy, allowing liver regeneration and survival through induction of H2-Bl/HLA-G
Ishikawa, Mayumi, Brooks, Andrew J., Fernández-Rojo, Manuel A., Medina, Johan, Chhabra, Yash, Minami, Shiro, Tunny, Kathryn A., Parton, Robert G., Vivian, Julian Philip, Rossjohn, Jamie, Chikani, Viral, Ramm, Grant A., Ho, Ken K.Y. and Waters, Michael J.. (2021). Growth hormone stops excessive inflammation after partial hepatectomy, allowing liver regeneration and survival through induction of H2-Bl/HLA-G. Hepatology. 73(2), pp. 759-775. https://doi.org/10.1002/hep.31297
The role of the HLA Class I α2 Helix in determining ligand hierarchy for the killer cell Ig-like Receptor 3DL1
Saunders, Philippa M., MacLachlan, Bruce J., Widjaja, Jacqueline, Wong, Shu Cheng, Oates, Clare V. L., Rossjohn, Jamie, Vivian, Julian P. and Brooks, Andrew G.. (2021). The role of the HLA Class I α2 Helix in determining ligand hierarchy for the killer cell Ig-like Receptor 3DL1. Journal of Immunology. 206(4), pp. 849-860. https://doi.org/10.4049/jimmunol.2001109
Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition
Mifsud, Nicole A., Illing, Patricia T., Lai, Jeffrey W., Fettke, Heidi, Hensen, Luca, Huang, Ziyi, Rossjohn, Jamie, Vivian, Julian Philip, Kwan, Patrick and Purcell, Anthony W.. (2021). Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition. Frontiers in Immunology. 12, p. Article 653710. https://doi.org/10.3389/fimmu.2021.653710
A pocket guide on how to structure SARS-CoV-2 drugs and therapies
Littler, Dene R., MacLachlan, Bruce J., Watson, Gabrielle M., Vivian, Julian Philip and Gully, Benjamin S.. (2020). A pocket guide on how to structure SARS-CoV-2 drugs and therapies. Biochemical Society Transactions. 48(6), pp. 2625-2641. https://doi.org/10.1042/BST20200396
Structural integrity with functional plasticity : What type I IFN receptor polymorphisms reveal
de Weerd, Nicole A., Vivian, Julian P., Lim, San S., Huang, Stephanie U-Shane and Hertzog, Paul J.. (2020). Structural integrity with functional plasticity : What type I IFN receptor polymorphisms reveal. Journal of Leukocyte Biology. 108(3), pp. 909-924. https://doi.org/10.1002/JLB.2MR0420-152R
The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function
Saunders, Philippa M., MacLachlan, Bruce J., Pymm, Phillip, Illing, Patricia T., Deng, Yuanchen, Wong, Shu Cheng, Oates, Clare V. L., Purcell, Anthony W., Rossjohn, Jamie, Vivian, Julian P. and Brooks, Andrew G.. (2020). The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function. Proceedings of the National Academy of Sciences of the United States of America. 117(21), pp. 11636-11647. https://doi.org/10.1073/pnas.1920570117
Downregulation of MHC class I expression by influenza A and B viruses
Koutsakos, Marios, McWilliam, Hamish E.G., Aktepe, Turgut E., Fritzlar, Svenja, Illing, Patricia T., Mifsud, Nicole A., Purcell, Anthony W., Rockman, Steve, Reading, Patrick C., Vivian, Julian P., Rossjohn, Jamie, Brooks, Andrew G., Mackenzie, Jason M., Mintern, Justine D., Villadangos, Jose A., Nguyen, Thi H. O. and Kedzierska, Katherine. (2019). Downregulation of MHC class I expression by influenza A and B viruses. Frontiers in Immunology. 10, p. Article 1158. https://doi.org/10.3389/fimmu.2019.01158
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
Martin, Maureen P., Naranbhai, Vivek, Shea, Patrick R., Qi, Ying, Ramsuran, Veron, Vince, Nicolas, Gao, Xiaojiang, Thomas, Rasmi, Brumme, Zabrina L., Carlson, Jonathan M., Wolinsky, Steven M., Goedert, James J., Walker, Bruce D., Segal, Florencia P., Deeks, Steven G., Haas, David W., Migueles, Stephen A., Connors, Mark, Michael, Nelson, ... Carrington, Mary. (2018). Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. Journal of Clinical Investigation. 128(5), pp. 1903-1912. https://doi.org/10.1172/JCI98463
HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome
Illing, Patricia T., Pymm, Phillip, Croft, Nathan P., Hilton, Hugo G., Jojic, Vladimir, Han, Alex S., Mendoza, Juan L., Mifsud, Nicole A., Dudek, Nadine L., McCluskey, James, Parham, Peter, Rossjohn, Jamie, Vivian, Julian P. and Purcell, Anthony W.. (2018). HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nature Communications. 9(1), p. Article 4693. https://doi.org/10.1038/s41467-018-07109-w
A subset of HLA-I peptides are not genomically templated : Evidence for cis- and trans-spliced peptide ligands
Faridi, Pouya, Li, Chen, Ramarathinam, Sri H., Vivian, Julian P., Illing, Patricia T., Mifsud, Nicole A., Ayala, Rochelle, Song, Jiangning, Gearing, Linden J., Hertzog, Paul J., Ternette, Nicola, Rossjohn, Jamie, Croft, Nathan P. and Purcell, Anthony W.. (2018). A subset of HLA-I peptides are not genomically templated : Evidence for cis- and trans-spliced peptide ligands. Science Immunology. 3(28), p. Article eaar3947. https://doi.org/10.1126/sciimmunol.aar3947